Catalent Inc

CTLT remains in a Stage 2 uptrend with EMAs stacked bullishly and a breakout to new highs, but price extension and elevated RSI suggest waiting for a pullback into the rising 20- to 50-day EMA zone before initiating a buy.

• ↑Novo’s $16.5 B buyout gives Catalent strong capital for R&D expansion.
• ↑Q1 FY2025 revenue of $1.02 B (+4% YoY) signals steady top-line growth.
• ↓Loss of public reporting reduces visibility into key financial KPIs.